Granulosa cell tumour primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 9: | Line 9: | ||
==Primary Prevention== | ==Primary Prevention== | ||
*There are no standard recommendations for screening for ovarian cancer | *There are no standard recommendations for screening for ovarian cancer. | ||
*BRCA testing may be done in women at high risk for ovarian cancer. | *[[BRCA]] testing may be done in women at high risk for ovarian cancer. | ||
*Removal of the ovaries and tubes in women who have a mutation in the BRCA1 and BRCA2 genes may reduce the risk of developing ovarian cancer, although ovarian cancer may still develop in other areas of the pelvis. | *Removal of the [[ovaries] and [[tubes]] in women who have a mutation in the BRCA1 and BRCA2 genes may reduce the risk of developing ovarian cancer, although ovarian cancer may still develop in other areas of the [[pelvis]]. | ||
==References== | ==References== | ||
Revision as of 13:26, 17 September 2012
Template:Granulosa cell tumour
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Primary Prevention
- There are no standard recommendations for screening for ovarian cancer.
- BRCA testing may be done in women at high risk for ovarian cancer.
- Removal of the [[ovaries] and tubes in women who have a mutation in the BRCA1 and BRCA2 genes may reduce the risk of developing ovarian cancer, although ovarian cancer may still develop in other areas of the pelvis.